Member Info for Schlum

Rather disappointing retrace, after such a positive RNS.

A surprisingly muted reaction to this positive RNS.

Indeed , the urgency to tackle the microplastics problem is only growing. North America, India and the EU are all potentially huge markets for Sym.

The delay in the permit/licence is suspicious.

Re your last sentence….indeed it is a surprise!

New 52 week high!

One would think that a large pharma would just pick up all the patents for £10m + and not miss a step.

Options at 10p…well, well. That is confidence.

With no positive news ,retail holders lose faith. Surely something is cooking somewhere.

Freehold of the Elephant and Castle site is worth many millions. A leaseback deal would be positive indeed.

As the accommodation is mostly 10+ beds to a room for those on limited means, it shows up politicians who decided three/four star hotels full board for illegals arriving in rubber boats, was the correct choice.

Metir [MET] announced a fundraiser today and plans to go ahead with its collaboration with Aptamer in marketing water pollution detection devices.

The revamped Modern Water product.

Very positive for company’s prospects for a stellar year ahead.

Extends beyond Nov 2025…. Should read.

Lots.. the cash runway extends Nov 2025 I would have thought. At the interims in March they suggested a year, subsequently Apta have done two more licensing deals with undisclosed up front payments and £250,000 fee for service contracts. There is also the agreed 10% royalty on product sales, which may be in 2026.

Indeed I recall that comment, he went on to mention a competitor company , albeit with $12m revenue, was taken over for $100m. Adrian believed that FAB’s Optimal would be a very interesting product for big pharma.

Personally I believe the link up with Queen’s University and all the resources and PhD students, that that entails, will usher in a step change in FAB’s story.

It does not mention the company behind the test, so unclear.

Telegraph article tonight suggest nhs to offer blood test for suspected lung cancer.

U.K. government export guarantee £1m grant funding must be available. The U.K. government is always ready to offer foreign companies eg Nissan or Tata loans in the billions.

MET has a huge market for its products. Great potential if managed astutely.

Some very experienced individuals now in place. Clearly they must see the potential in N4P.